Sandra Levy
ARTICLES BY THIS AUTHOR
- 2/8/2022
Kroger’s Tuffin announces retirement
Mark Tuffin, senior vice president of retail divisions, will retire in April and Kenny Kimball will succeed him. - 2/8/2022
CVS Health surpasses expectations in Q4, reaffirms 2022 outlook
CVS Health posted fourth-quarter revenues of $76.6 billion and reported a net income decrease of 11.7% for the quarter and 5.2% for the year. - 2/8/2022
Amazon Care telehealth service goes nationwide
Amazon plans to bring in-person care services to more than 20 additional cities including San Francisco, Miami, Chicago and New York City. - 2/8/2022
FDA approves Mylan’s generic Restasis
The first generic of Restasis is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. - 2/7/2022
ANI intros Cortrophin Gel
Cortrophin Gel is indicated for the treatment of certain chronic autoimmune disorders, including acute exacerbations of multiple sclerosis and rheumatoid arthritis and excess urinary protein due to nephrotic syndrome. - 2/7/2022
Dr. Reddy’s Aurigene Pharmaceutical Services names CEO
Akhil Ravi has served as Dr. Reddy’s head of strategy for services and active pharmaceutical ingredients and headed the sales of APIs in Europe. - 2/7/2022
Hy-Vee to debut reimagined store
The store will feature several new departments, as well as amenities the company has become known for. - 2/7/2022
SpartanNash, Flashfood expand upon food waste reduction pilot
The program aims to save hundreds of thousands of pounds of food from landfills while offering steep discounts to grocery store guests. - 2/7/2022
NACDS applauds House-passed advancement of Inform Consumers Act
The Inform Consumers Act would curb the flow of stolen and counterfeit merchandise, and help protect consumers and retailers from organized retail crime. - 2/6/2022
Avalere analysis examines Medicare Part D’s plan tier placement of generics
Avalere’s examination of Medicare Part D plan tier placement of generic prescription drugs found that over time their percentage on generic tiers has declined from 65% in 2016 to 43% in 2022.
